Topics - Drug Development
Refine By
Content Type
FeaturesBreaking News
Columns
Editorial
Online Exclusives
Industry News
Industry Events
Buyers Guide Companies
Business Corner
Expert's Opinion
White Papers / Tech Papers
Classifieds
Services
Product Releases
Case Studies
Top Companies Report
Jobs
Videos
Collaborations & Alliances
Promotions & Movies
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
Advanced Degrees
Financial Analysis
I Mak
Lowe Down
Managing Your Careeer
Pharma Beat
Preclinical Outsourcing
Salary Survey
Outsourcing Survey
Contracting & Outsourcing
Literature / Brochures
CRO News
FDA Watch
India Report
Executive Perspective
Ask The Board
Glossary
Posters
News Releases
Provider Survey
Conference Sessions
Ask The Experts
Published May 17, 2013
Will leverage chemical and biological expertise Read More »
Published May 17, 2013
To include Crohn's disease in GLPG0634 program Read More »
Published May 16, 2013
RYI-008 has the potential to treat autoimmune diseases and cancer Read More »
Published May 15, 2013
AbbVie gains option to acquire ALV003 assets or equity Read More »
Published May 14, 2013
Launches translational medicine program Read More »
Published May 14, 2013
CMC will use CHEF1 system for cell line development Read More »
Published May 9, 2013
Forest will have the option to exclusively license heart drug Read More »
Published May 7, 2013
Will focus on drug resistant bacteria and viral infections Read More »
Published May 6, 2013
Will commit resources to global Oraxol, Oratecan Read More »
Published May 3, 2013
Deal worth as much as $50 million, plus royalties Read More »
Published May 3, 2013
Will use Ambrx's protein med-chem tech Read More »
Published April 30, 2013
Expands presence in oncology, inflammation and autoimmune diseases Read More »
Published April 29, 2013
Shin Poong to develop and market ALM201 in South Korea Read More »
Published April 29, 2013
Will combine SGLT2 inhibitor with Januvia Read More »
